263 related articles for article (PubMed ID: 22385797)
21. The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy--results from the randomized DAHANCA 5 study.
Hoff CM; Hansen HS; Overgaard M; Grau C; Johansen J; Bentzen J; Overgaard J
Radiother Oncol; 2011 Jan; 98(1):28-33. PubMed ID: 20970213
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic.
Curtis KK; Ross HJ; Garrett AL; Jizba TA; Patel AB; Patel SH; Wong WW; Halyard MY; Ko SJ; Kosiorek HE; Foote RL
Radiat Oncol; 2016 Apr; 11():55. PubMed ID: 27061083
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
24. Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck.
Fortin A; Wang CS; Vigneault E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1062-9. PubMed ID: 19036528
[TBL] [Abstract][Full Text] [Related]
25. The impact of blood hemoglobin content on the outcome of radiotherapy. The Freiburg experience.
Frommhold H; Guttenberger R; Henke M
Strahlenther Onkol; 1998 Dec; 174 Suppl 4():31-4. PubMed ID: 9879345
[TBL] [Abstract][Full Text] [Related]
26. Oxygen and Perfusion Kinetics in Response to Fractionated Radiation Therapy in FaDu Head and Neck Cancer Xenografts Are Related to Treatment Outcome.
Hu F; Vishwanath K; Salama JK; Erkanli A; Peterson B; Oleson JR; Lee WT; Brizel DM; Ramanujam N; Dewhirst MW
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):462-469. PubMed ID: 27598811
[TBL] [Abstract][Full Text] [Related]
27. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
28. Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
Murakami N; Matsumoto F; Yoshimoto S; Ito Y; Mori T; Ueno T; Tuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Inaba K; Igaki H; Itami J
BMC Cancer; 2016 Mar; 16():192. PubMed ID: 26951089
[TBL] [Abstract][Full Text] [Related]
29. Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients?
Choi SH; Terrell JE; Bradford CR; Ghanem T; Spector ME; Wolf GT; Lipkus IM; Duffy SA
Nicotine Tob Res; 2016 Dec; 18(12):2216-2224. PubMed ID: 27613928
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck.
Pradier O; Christiansen H; Schmidberger H; Martin A; Jäckel MC; Steiner W; Ambrosch P; Kahler E; Hess CF
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1368-77. PubMed ID: 16169679
[TBL] [Abstract][Full Text] [Related]
32. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
[TBL] [Abstract][Full Text] [Related]
33. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
[TBL] [Abstract][Full Text] [Related]
34. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03.
Rabinovitch R; Grant B; Berkey BA; Raben D; Ang KK; Fu KK; Cooper JS;
Head Neck; 2006 Apr; 28(4):287-96. PubMed ID: 16287132
[TBL] [Abstract][Full Text] [Related]
35. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
[TBL] [Abstract][Full Text] [Related]
36. The effect of low hemoglobin levels on outcomes of radiotherapy following microscopically complete resection of locally advanced SCCHN: Implications for the future.
Rades D; Seidl D; Janssen S; Wollenberg B; Hakim SG; Schild SE
J Craniomaxillofac Surg; 2016 Sep; 44(9):1441-4. PubMed ID: 27470216
[TBL] [Abstract][Full Text] [Related]
37. Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma--the ARTSCAN study.
Zackrisson B; Nilsson P; Kjellén E; Johansson KA; Modig H; Brun E; Nyman J; Friesland S; Reizenstein J; Sjödin H; Ekberg L; Lödén B; Mercke C; Fernberg JO; Franzén L; Ask A; Persson E; Wickart-Johansson G; Lewin F; Wittgren L; Björ O; Björk-Eriksson T
Radiother Oncol; 2011 Jul; 100(1):41-8. PubMed ID: 21295880
[TBL] [Abstract][Full Text] [Related]
38. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
39. Survival Patterns in Elderly Head and Neck Squamous Cell Carcinoma Patients Treated With Definitive Radiation Therapy.
Sommers LW; Steenbakkers RJHM; Bijl HP; Vemer-van den Hoek JGM; Roodenburg JLN; Oosting SF; Halmos GB; de Rooij SE; Langendijk JA
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):793-801. PubMed ID: 28476434
[TBL] [Abstract][Full Text] [Related]
40. The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma.
Lyhne NM; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Evensen J; Mortensen HR; Overgaard J
Radiother Oncol; 2015 Oct; 117(1):91-8. PubMed ID: 26255764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]